EMPLOYMENT AGREEMENTEmployment Agreement • January 29th, 2024 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 29th, 2024 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 25th day of January, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company (the “Company”) and JENNIFER L. CALLAHAN, whose address is 1901 W. 47th, Kansas City, KS 66205, (the “Executive”). (The Company and the Executive hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis AGREEMENT (the “Agreement”) is made and effective as of the 23rd day of September, 2021 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and LAURIE A. MYERS, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2021 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and MATTHEW N. BRAMS, whose address is [**] (the “Employee”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2021 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and SHANE J. SCHAFFER, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2021 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company (the “Company”) and LOUIS G. VAN HORN, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2021 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and CRAIG S. GILGALLON, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2021 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and RAUL R. SILVA, whose address is [**] (the “Employee”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Cingulate Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 1st day of January, 2021 by and between CINGULATE INC., a Delaware corporation, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and RAUL R. SILVA, whose address is [**] (the “Employee”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Cingulate Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 1st day of January, 2021 by and between CINGULATE INC., a Delaware corporation, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and LOUIS G. VAN HORN, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Cingulate Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 1st day of January, 2021 by and between CINGULATE INC., a Delaware corporation, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and SHANE J. SCHAFFER, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Cingulate Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis AGREEMENT (the “Agreement”) is made and effective as of the 1st day of January, 2021 by and between CINGULATE INC., a Delaware corporation, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and LAURIE A. MYERS, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Cingulate Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 1st day of January, 2021 by and between CINGULATE INC., a Delaware corporation, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and CRAIG S. GILGALLON, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Cingulate Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and effective as of this 1st day of January, 2021 by and between CINGULATE INC., a Delaware corporation, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and MATTHEW N. BRAMS, whose address is [**] (the “Employee”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)